Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
Sales | 4,969,000 | 4,354,000 | 1,937,000 | 571,000 | 157,000 |
Cost of Goods | 722,000 | 750,000 | 193,000 | N/A | 0 |
Gross Profit | 4,247,000 | 3,604,000 | 1,744,000 | 563,000 | 157,000 |
Operating Expenses | 689,000 | 542,000 | 478,000 | 846,000 | 392,000 |
Operating Income | 3,558,000 | 3,062,000 | 1,266,000 | -275,000 | -235,000 |
Other Income | -6,000 | 1,000 | -6,000 | 4,000 | 3,000 |
Pre-tax Income | 3,552,000 | 3,063,000 | 1,260,000 | -271,000 | -232,000 |
Income Tax | 219,000 | 283,000 | 39,000 | 2,000 | 1,000 |
Net Income Continuous | 3,333,000 | 2,780,000 | 1,221,000 | -273,000 | -233,000 |
Net Income | $3,333,000 | $2,780,000 | $1,221,000 | $-273,000 | $-233,000 |
EPS Basic Total Ops | 8.27 | 6.93 | 3.05 | -0.71 | -0.59 |
EPS Basic Continuous Ops | 8.25 | 6.92 | 3.05 | -0.71 | -0.59 |
EPS Diluted Total Ops | 7.70 | 6.46 | 2.84 | -0.71 | -0.59 |
EPS Diluted Continuous Ops | 7.68 | 6.45 | 2.84 | -0.71 | -0.59 |
EBITDA(a) | $3,648,000 | $3,139,000 | $1,286,000 | $-263,000 | $-223,000 |